ColinThomasMD
Oncology • Philadelphia, PAHematologic Oncology
Assistant Professor of Clinical Medicine, Perelman School of Medicine
Dr. Thomas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Abramson Cancer Center
PCAM
Philadelphia, PA 19104
Summary
- Dr. Colin Thomas is an oncologist in Philadelphia, PA and is affiliated with Hospital of the University of Pennsylvania. He received his medical degree from Lewis Katz School of Medicine at Temple University and has been in practice 2 years. He specializes in hematologic oncology and is experienced in T-cell lymphomas, cutaneous lymphomas, sezary syndrome, chronic lymphoid leukemia, b-cell lymphomas, and diffuse large b-cell lymphoma. He has more than 20 publications and over 150 citings.
Education & Training
Lewis Katz School of Medicine at Temple UniversityClass of 2016
Certifications & Licensure
PA State Medical License 2019 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- SOHO Young Investigator Scholarship Society of Hematologic Oncology, 2024
- ASCO Young Investigator Award 2022
- Lymphoma Research Foundation Scholarship 2022
Publications & Presentations
PubMed
- Retrospective cohort study of novel oral agents lenalidomide and duvelisib for relapsed or refractory mycosis fungoides and Sézary syndrome.Omar Elghawy, Austin G Yang, Jonathan H Sussman, Colin J Thomas, Jordan S Carter
Journal of the American Academy of Dermatology. 2024-11-16 - 1 citationsEvaluation of Ki-67 expression and large cell content as prognostic markers in MZL: a multicenter cohort study.Natalie S Grover, Kaitlin Annunzio, Marcus Watkins, Pallawi Torka, Reem Karmali
Blood Cancer Journal. 2024-10-18 - Prevalence and Prognostication of CD5+ Mature T-Cell Lymphomas.Omar Elghawy, Miao Cao, Jason Xu, Daniel J Landsburg, Jakub Svoboda
Cancers. 2024-10-09
Press Mentions
Health Officials Say Now Is Time to Protect Yourself During Respiratory Disease SeasonOctober 20th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
